pH gradient Analysis of Adalimumab charge variant

Significance of the Topic

Adalimumab, a monoclonal antibody therapeutic, exhibits charge heterogeneity that impacts its biological activity, stability, and safety. Accurate profiling of these charge variants is critical for quality control in biopharmaceutical development and manufacturing.

Study Objectives and Overview

• Establish a robust pH gradient ion‐exchange chromatography (IEX) method for detailed charge variant analysis of adalimumab.
• Assess method performance in terms of resolution, reproducibility, and run time using Shimadzu instrumentation.

Methodology and Instrumentation

• Instrumentation Used
  • Nexera lite inert UHPLC system
  • Shim‐pack Bio IEX SP‐NP column (100 mm × 4.6 mm I.D., 5 μm)
  • Shim‐vial H glass vials
• Mobile Phase Composition
  • Phase A: 20 mmol/L MES–HEPES–sodium acetate buffer, pH 4.0
  • Phase B: 20 mmol/L MES–HEPES–sodium acetate buffer, pH 10.6
• Gradient Program
  • 0 % B at 0 min to 100 % B at 20–25 min
  • Return to 0 % B at 25.1 min and re‐equilibrate until 30 min
• Flow Rate: 0.6 mL/min
• Injection Volume: 10 µL
• Column Temperature: Ambient
• Detection: UV absorbance at 280 nm

Main Results and Discussion

• The method achieved baseline separation of acidic, main, and basic adalimumab variants within a 30 min run.
• Subtle charge isoforms were resolved with high peak symmetry and reproducibility across replicate injections.
• Buffer pH ramp provided controlled elution and minimized peak broadening, confirming method robustness.

Benefits and Practical Applications

• High resolution of charge variants supports stringent quality control and batch release testing in biopharma.
• Rapid analysis cycle enhances laboratory throughput and reduces operational costs.
• Ambient column conditions and stable buffer system extend column longevity and reduce maintenance.

Future Trends and Applications

• Integration with mass spectrometry for direct identification of charge variant species.
• Automation and online data processing for high-throughput screening of biotherapeutics.
• Method adaptation for a broad range of monoclonal antibodies and biosimilars to streamline comparability studies.

Conclusion

The described pH gradient IEX method on a Shim-pack Bio IEX SP-NP column using a Nexera lite inert system delivers reliable, high‐resolution separation of adalimumab charge variants. Its robustness and ease of use make it well suited for routine quality assurance in biopharmaceutical laboratories.